Leukemia News

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.

Persistent FLT3-internal tandem duplication or NPM1 variants in the blood of patients with acute myeloid leukemia in first remission before transplant appeared associated with higher risk for relapse and death, according to a study in JAMA.

In this edition, optimal antibiotics timing among inpatients with cancer; inflammation levels linked to survival in acute myeloid leukemia; dexrazoxane confers long-term cardioprotection for pediatric cancer and more.

Despite an overall positive safety outlook, the scope of potential toxicities related to chimeric antigen receptor T-cell therapy remains unclear due to lack of long-term follow-up.

The FDA announced several regulatory actions the past few weeks.

Miguel-Angel Perales, MD, has been named president of American Society for Transplantation and Cellular Therapy for 2023-2024.

Carl H. June, MD, will receive this year’s AACR Award for Lifetime Achievement in Cancer Research.

Researchers at Cancer Care Alberta and University of Calgary have demonstrated the value of a cancer symptom algorithm in correctly identifying which patients may be at high risk for an unplanned ED visit.

More than half of patients with two common acute leukemia subtypes exhibited a clinical response to the investigational therapy revumenib, results of the AUGMENT-101 trial showed.